Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction - Implications for patients with and without recognized diabetes

被引:503
作者
Kosiborod, M
Rathore, SS
Inzucchi, SE
Masoudi, FA
Wang, YF
Havranek, EP
Krumholz, HM
机构
[1] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA
[5] Yale Univ, Sch Med, Sect Hlth Policy & Adm, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[6] Yale Univ, New Haven Hlth Ctr Outcomes Res & Evaluat, New Haven, CT USA
[7] Denver Hlth Med Ctr, Dept Med, Div Cardiol, Denver, CO USA
关键词
diabetes mellitus; elderly; glucose; mortality; myocardial infarction;
D O I
10.1161/CIRCULATIONAHA.104.517839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - The relationship between admission glucose levels and outcomes in older diabetic and nondiabetic patients with acute myocardial infarction is not well defined. Methods and Results - We evaluated a national sample of elderly patients (n = 141 680) hospitalized with acute myocardial infarction from 1994 to 1996. Admission glucose was analyzed as a categorical (<= 110, > 110 to 140, > 140 to 170, > 170 to 240, > 240 mg/dL) and continuous variable for its association with mortality in patients with and without recognized diabetes. A substantial proportion of hyperglycemic patients (eg, 26% of those with glucose > 240 mg/dL) did not have recognized diabetes. Fewer hyperglycemic patients without known diabetes received insulin during hospitalization than diabetics with similar glucose levels (eg, glucose > 240 mg/dL, 22% versus 73%; P < 0.001). Higher glucose levels were associated with greater risk of 30-day mortality in patients without known diabetes ( for glucose range from > 110 to > 240 mg/dL, 10% to 39%) compared with diabetics ( range, 16% to 24%; P for interaction < 0.001). After multivariable adjustment, higher glucose levels continued to be associated with a graded increase in 30-day mortality in patients without known diabetes ( referent, glucose <= 110 mg/dL; range from glucose > 110 to 140 mg/dL: hazard ratio [HR], 1.17; 95% CI, 1.11 to 1.24; to glucose > 240 mg/dL: HR, 1.87; 95% CI, 1.75 to 2.00). In contrast, among diabetic patients, greater mortality risk was observed only in those with glucose > 240 mg/dL ( HR, 1.32; 95% CI, 1.17 to 1.50 versus glucose <= 110 mg/dL; P for interaction < 0.001). One-year mortality results were similar. Conclusions - Elevated glucose is common, rarely treated, and associated with increased mortality risk in elderly acute myocardial infarction patients, particularly those without recognized diabetes.
引用
收藏
页码:3078 / 3086
页数:9
相关论文
共 58 条
[1]  
*AM HOSP ASS, 1979, AHA ANN SURV FISC YE
[2]  
ANTMAN EM, 2005, ACC AHA GUIDELINES M
[3]   HYPERGLYCEMIA AND PROGNOSIS OF ACUTE MYOCARDIAL-INFARCTION IN PATIENTS WITHOUT DIABETES-MELLITUS [J].
BELLODI, G ;
MANICARDI, V ;
MALAVASI, V ;
VENERI, L ;
BERNINI, G ;
BOSSINI, P ;
DISTEFANO, S ;
MAGNANINI, G ;
MURATORI, L ;
ROSSI, G ;
ZUARINI, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (14) :885-888
[4]   Impaired glucose metabolism predicts mortality after a myocardial infarction [J].
Bolk, J ;
van der Ploeg, T ;
Cornel, JH ;
Arnold, AER ;
Sepers, J ;
Umans, VAWM .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 79 (2-3) :207-214
[5]   ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-Segment elevation myocardial infarction - Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) [J].
Braunwald, E ;
Antman, EM ;
Beasley, JW ;
Califf, RM ;
Cheitlin, MD ;
Hochman, JS ;
Jones, RH ;
Kereiakes, D ;
Kupersmith, J ;
Levin, TN ;
Pepine, CJ ;
Schaeffer, JW ;
Smith, EE ;
Steward, DE ;
Theroux, P ;
Gibbons, RJ ;
Alpert, JS ;
Faxon, DP ;
Fuster, V ;
Gregoratos, G ;
Hiratzka, LF ;
Jacobs, AK ;
Smith, SC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (07) :1366-1374
[6]   Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview [J].
Capes, SE ;
Hunt, D ;
Malmberg, K ;
Gerstein, HC .
LANCET, 2000, 355 (9206) :773-778
[7]   Management of diabetes and is hyperglycemia in hospitals [J].
Clement, S ;
Braithwaite, SS ;
Magee, MF ;
Ahmann, A ;
Smith, EP ;
Schafer, RG ;
Hirsh, IB .
DIABETES CARE, 2004, 27 (02) :553-591
[8]   The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and those with unspecified hyperglycemia [J].
Dandona, P ;
Aljada, A ;
Bandyopadhyay, A .
DIABETES CARE, 2003, 26 (02) :516-519
[9]  
*DEP HHS, 1989, INT CLASS DIS
[10]   Metabolic modulation of acute myocardial infarction -: The ECLA glucose-insulin-potassium pilot trial [J].
Díaz, R ;
Paolasso, A ;
Piegas, LS ;
Tajer, CD ;
Moreno, MG ;
Corvalán, R ;
Isea, JE ;
Romero, G .
CIRCULATION, 1998, 98 (21) :2227-2234